Return to search

LUCA Science pockets $9.8m Series A

LUCA Science, an Japanese developer of functional mitochondria as therapeutic agents, has raised $9.8 million in Series A financing.

LUCA Science, an Japanese developer of functional mitochondria as therapeutic agents, has raised $9.8 million in Series A financing. Axil Capital Partners led the round with participation from other investors that included Remiges Ventures, Nippon Venture Capital, Fast Track Initiative and CaHC.

Source: Press Release